RPL17P44

Across TCGA pan-cancer cohorts, RPL17P44 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPL17P44’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPL17P44 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL17P44 is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

COAD and LUAD are the cancer types where RPL17P44 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL17P44 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	IV	−0.160	.018	3	view →
LUAD	Female	All	+0.109	.010	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RPL17P44–COAD

Open the COAD breakdown →